{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T14:02:43Z","timestamp":1765807363476},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Servier Hellas"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12913-016-1779-6","type":"journal-article","created":{"date-parts":[[2016,9,27]],"date-time":"2016-09-27T12:23:23Z","timestamp":1474979003000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Economic evaluation of trimetazidine in the management of chronic stable angina in Greece"],"prefix":"10.1186","volume":"16","author":[{"given":"Georgia","family":"Kourlaba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Gourzoulidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Andrikopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Tsioufis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Beletsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos","family":"Maniadakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,9,27]]},"reference":[{"key":"1779_CR1","unstructured":"American Heart Association. Angina Pectoris (Stable Angina). 2014. http:\/\/www.heart.org\/HEARTORG\/Conditions\/HeartAttack\/SymptomsDiagnosisofHeartAttack\/Angina-Pectoris-Stable-Angina_UCM_437515_Article.jsp . Accessed 8 Jan 2015."},{"issue":"2","key":"1779_CR2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jama.290.2.215","volume":"290","author":"B Ruo","year":"2003","unstructured":"Ruo B, Rumsfeld JS, Hlatky MA, Liu H, Browner WS, Whooley MA. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003;290(2):215\u201321.","journal-title":"JAMA"},{"issue":"1","key":"1779_CR3","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/140174302317282375","volume":"36","author":"I Karlsson","year":"2002","unstructured":"Karlsson I, Rasmussen C, Ravn J, Thiis JJ, Pettersson G, Larsso PA. Chest pain after coronary artery bypass: relation to coping capacity and quality of life. Scand Cardiovasc J. 2002;36(1):41\u20137.","journal-title":"Scand Cardiovasc J"},{"issue":"10","key":"1779_CR4","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1023\/A:1016606521786","volume":"9","author":"PE Wandell","year":"2000","unstructured":"Wandell PE, Brorsson B. Assessing sexual functioning in patients with chronic disorders by using a generic health-related quality of life questionnaire. Qual Life Res. 2000;9(10):1081\u201392.","journal-title":"Qual Life Res"},{"issue":"1","key":"1779_CR5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1161\/01.CIR.0000020688.24874.90","volume":"106","author":"JA Spertus","year":"2002","unstructured":"Spertus JA, Jones P, McDonell M, Fan V, Fihn SD. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 2002;106(1):43\u20139.","journal-title":"Circulation"},{"issue":"8","key":"1779_CR6","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1136\/heart.89.8.848","volume":"89","author":"S Stewart","year":"2003","unstructured":"Stewart S, Murphy NF, Walker A, McGuire A, McMurray JJ. The current cost of angina pectoris to the National Health Service in the UK. Heart. 2003;89(8):848\u201353.","journal-title":"Heart"},{"issue":"9289","key":"1779_CR7","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0140-6736(01)06343-7","volume":"358","author":"S Capewell","year":"2001","unstructured":"Capewell S, MacIntyre K, Stewart S, Chalmers JW, Boyd J, Finlayson A, et al. Age, sex, and social trends in out-of-hospital cardiac deaths in Scotland 1986-95: a retrospective cohort study. Lancet. 2001;358(9289):1213\u20137.","journal-title":"Lancet"},{"issue":"11 Suppl","key":"1779_CR8","first-page":"S347","volume":"10","author":"MW Reynolds","year":"2004","unstructured":"Reynolds MW, Frame D, Scheye R, Rose ME, George S, Watson JB, et al. A systematic review of the economic burden of chronic angina. Am J Manag Care. 2004;10(11 Suppl):S347\u201357.","journal-title":"Am J Manag Care"},{"issue":"4","key":"1779_CR9","first-page":"272","volume":"55","author":"G Andrikopoulos","year":"2014","unstructured":"Andrikopoulos G, Parissis J, Filippatos G, Nikolaou M, Pantos K, Voudris V, et al. Medical management of stable angina. Hellenic J Cardiol. 2014;55(4):272\u201380.","journal-title":"Hellenic J Cardiol"},{"issue":"10","key":"1779_CR10","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.acvd.2011.08.001","volume":"104","author":"JL Gayet","year":"2011","unstructured":"Gayet JL, Paganelli F, Cohen-Solal A. Update on the medical treatment of stable angina. Arch Cardiovasc Dis. 2011;104(10):536\u201344.","journal-title":"Arch Cardiovasc Dis"},{"issue":"1","key":"1779_CR11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.7861\/clinmedicine.13-1-63","volume":"13","author":"JM Tarkin","year":"2013","unstructured":"Tarkin JM, Kaski JC. Pharmacological treatment of chronic stable angina pectoris. Clin Med. 2013;13(1):63\u201370.","journal-title":"Clin Med"},{"issue":"9","key":"1779_CR12","first-page":"1569","volume":"19","author":"K Siama","year":"2013","unstructured":"Siama K, Tousoulis D, Papageorgiou N, Siasos G, Tsiamis E, Bakogiannis C, et al. Stable angina pectoris: current medical treatment. Curr Pharm Des. 2013;19(9):1569\u201380.","journal-title":"Curr Pharm Des"},{"issue":"15","key":"1779_CR13","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O\u2019Rourke RA, Teo KK, Hartigan PM, Maron DJ, Kostuk WJ, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503\u201316.","journal-title":"N Engl J Med"},{"issue":"6","key":"1779_CR14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.CIR.0000048143.25023.87","volume":"107","author":"JS Borer","year":"2003","unstructured":"Borer JS, Fox K, Jaillon P, Lerebours G, Ivabradine Investigators G. Antianginal and antiischemic effects of ivabradine, an I(f) inhibitor, in stable angina: a randomized, double-blind, multicentered, placebo-controlled trial. Circulation. 2003;107(6):817\u201323.","journal-title":"Circulation"},{"issue":"11","key":"1779_CR15","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.amjcard.2005.01.069","volume":"95","author":"BR Chaitman","year":"2005","unstructured":"Chaitman BR, Ivleva AY, Ujda M, Lenis JH, Toth C, Stieber DM, et al. Antianginal efficacy of omapatrilat in patients with chronic angina pectoris. Am J Cardiol. 2005;95(11):1283\u20139.","journal-title":"Am J Cardiol"},{"issue":"23","key":"1779_CR16","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1093\/eurheartj\/ehi586","volume":"26","author":"JC Tardif","year":"2005","unstructured":"Tardif JC, Ford I, Tendera M, Bourassa MG, Fox K, Investigators I. Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina. Eur Heart J. 2005;26(23):2529\u201336.","journal-title":"Eur Heart J"},{"issue":"10","key":"1779_CR17","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.07.047","volume":"46","author":"RM Vicari","year":"2005","unstructured":"Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, et al. Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005;46(10):1803\u201311.","journal-title":"J Am Coll Cardiol"},{"key":"1779_CR18","first-page":"CD003614","volume":"4","author":"A Ciapponi","year":"2005","unstructured":"Ciapponi A, Pizarro R, Harrison J. Trimetazidine for stable angina. Cochrane Database Syst Rev. 2005;4:CD003614.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"1779_CR19","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1161\/01.RES.86.5.580","volume":"86","author":"PF Kantor","year":"2000","unstructured":"Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circ Res. 2000;86(5):580\u20138.","journal-title":"Circ Res"},{"issue":"1","key":"1779_CR20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207\u201358.","journal-title":"Physiol Rev"},{"issue":"Suppl 4","key":"1779_CR21","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/BF00051292","volume":"4","author":"S Dalla-Volta","year":"1990","unstructured":"Dalla-Volta S, Maraglino G, Della-Valentina P, Viena P, Desideri A. Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study. Cardiovasc Drugs Ther. 1990;4 Suppl 4:853\u20139.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"24","key":"1779_CR22","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1053\/euhj.2001.2896","volume":"22","author":"H Szwed","year":"2001","unstructured":"Szwed H, Sadowski Z, Elikowski W, Koronkiewicz A, Mamcarz A, Orszulak W, et al. Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand. Eur Heart J. 2001;22(24):2267\u201374.","journal-title":"Eur Heart J"},{"key":"1779_CR23","unstructured":"European Medicines Agency. Recommends restricting use of trimetazidine-containing medicines. 2012. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2012\/06\/WC500129070.pdf . Accessed 1 Dec 2014."},{"issue":"8","key":"1779_CR24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.amjcard.2014.01.407","volume":"113","author":"CG Kohn","year":"2014","unstructured":"Kohn CG, Parker MW, Limone BL, Coleman CI. Cost-effectiveness of ranolazine added to standard-of-care treatment in patients with chronic stable angina pectoris. Am J Cardiol. 2014;113(8):1306\u201311.","journal-title":"Am J Cardiol"},{"issue":"2","key":"1779_CR25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000332369","volume":"120","author":"N Danchin","year":"2011","unstructured":"Danchin N, Marzilli M, Parkhomenko A, Ribeiro JP. Efficacy comparison of trimetazidine with therapeutic alternatives in stable angina pectoris: a network meta-analysis. Cardiology. 2011;120(2):59\u201372.","journal-title":"Cardiology"},{"issue":"4","key":"1779_CR26","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s10198-005-0309-y","volume":"6","author":"L Longworth","year":"2005","unstructured":"Longworth L, Buxton MJ, Sculpher M, Smith DH. Estimating utility data from clinical indicators for patients with stable angina. Eur J Health Econ. 2005;6(4):347\u201353.","journal-title":"Eur J Health Econ"},{"issue":"9","key":"1779_CR27","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s10198-013-0534-8","volume":"15","author":"A Hidalgo-Vega","year":"2013","unstructured":"Hidalgo-Vega A, Ramos-Goni JM, Villoro R. Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain. Eur J Health Econ. 2013;15(9):917\u201325.","journal-title":"Eur J Health Econ"},{"key":"1779_CR28","unstructured":"Greek Ministry of Health. Drug price bulletin. http:\/\/www.yyka.gov.gr\/ . Accessed 23 Dec 2014."},{"issue":"6","key":"1779_CR29","first-page":"442","volume":"55","author":"E Sbarouni","year":"2014","unstructured":"Sbarouni E, Voudris V, Georgiadou P, Hamilos M, Steg PG, Fox KM, et al. Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort. Hellenic J Cardiol. 2014;55(6):442\u20137.","journal-title":"Hellenic J Cardiol"},{"key":"1779_CR30","unstructured":"Greek Ministry of Health. Diagnostic Related Groups. Athens. http:\/\/www.yyka.gov.gr\/articles\/health\/domes-kai-draseis-gia-thn-ygeia\/kwdikopoihseis\/709-kleista-enopoihmena-noshlia-1 . Accessed 8 Feb 2012."},{"key":"1779_CR31","unstructured":"WHO. Choosing interventions that are Cost Effective (WHO-CHOICE): Cost-effectiveness thresholds. 2013. http:\/\/www.who.int\/choice\/costs\/CER_thresholds\/en\/index.html . Accessed 14 Feb 2015."},{"key":"1779_CR32","unstructured":"International Monetary Fund. World Economic Outlook Database. 2013. http:\/\/www.imf.org\/external\/pubs\/ft\/weo\/2012\/02\/weodata\/index.aspx . Accessed 15 Feb 2015."},{"key":"1779_CR33","doi-asserted-by":"crossref","DOI":"10.1093\/oso\/9780198526629.001.0001","volume-title":"Decision modelling for health economic evaluation. Handbooks in health economic evaluation","author":"A Briggs","year":"2006","unstructured":"Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Handbooks in health economic evaluation. New York: Oxford University Press Inc; 2006."},{"issue":"2","key":"1779_CR34","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.ijcard.2012.11.001","volume":"168","author":"C Vitale","year":"2013","unstructured":"Vitale C, Spoletini I, Malorni W, Perrone-Filardi P, Volterrani M, et al. Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina--the VASCO-angina study. Int J Cardiol. 2013;168(2):1078\u201381.","journal-title":"Int J Cardiol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-016-1779-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T16:29:19Z","timestamp":1718814559000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-016-1779-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,27]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1779"],"URL":"https:\/\/doi.org\/10.1186\/s12913-016-1779-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,27]]},"article-number":"520"}}